Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Victoria Mar

Showing results (71-80 of 75) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 75 results.
Trials|May 5, 2021
Can patient-led surveillance detect subsequent new primary or recurrent melanomas and reduce the need for routinely scheduled follow-up? A protocol for the MEL-SELF randomised controlled trialDeonna M Ackermann, Amelia K Smit, Monika Janda, et al.
JAMA Oncology|January 29, 2026
Cancer Incidence and Mortality With Aspirin in Older Adults: Follow-Up of the ASPREE TrialSuzanne G Orchard, Galina Polekhina, John Zalcberg, et al.
JAMA Dermatology|November 24, 2021
Assessing the Potential for Patient-led Surveillance After Treatment of Localized Melanoma (MEL-SELF): A Pilot Randomized Clinical TrialDeonna M Ackermann, Mbathio Dieng, Ellie Medcalf, et al.
JAMA Dermatology|March 11, 2026
Characteristics of Participants Screened and Randomized to the Melanoma Self Surveillance TrialEllie Medcalf, Deonna M Ackermann, Jake T W Williams, et al.
Nature Communications|December 8, 2025
Predictive models of melanoma metastasis based on dermatoscopy in an international retrospective human reader studyKonstantinos Lallas, Harald Kittler, Philipp Tschandl, et al.
Pageof 8

Showing results (71-80 of 75) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 75 results.
Trials|May 5, 2021
Can patient-led surveillance detect subsequent new primary or recurrent melanomas and reduce the need for routinely scheduled follow-up? A protocol for the MEL-SELF randomised controlled trialDeonna M Ackermann, Amelia K Smit, Monika Janda, et al.
JAMA Oncology|January 29, 2026
Cancer Incidence and Mortality With Aspirin in Older Adults: Follow-Up of the ASPREE TrialSuzanne G Orchard, Galina Polekhina, John Zalcberg, et al.
JAMA Dermatology|November 24, 2021
Assessing the Potential for Patient-led Surveillance After Treatment of Localized Melanoma (MEL-SELF): A Pilot Randomized Clinical TrialDeonna M Ackermann, Mbathio Dieng, Ellie Medcalf, et al.
JAMA Dermatology|March 11, 2026
Characteristics of Participants Screened and Randomized to the Melanoma Self Surveillance TrialEllie Medcalf, Deonna M Ackermann, Jake T W Williams, et al.
Nature Communications|December 8, 2025
Predictive models of melanoma metastasis based on dermatoscopy in an international retrospective human reader studyKonstantinos Lallas, Harald Kittler, Philipp Tschandl, et al.
Pageof 8